- Published
- 05 April 2023
- Journal article
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19
- Authors
-
- Source
- Genome Medicine
Abstract
Background
We previously reported that impaired type I IFN activity, due to inborn errors of TLR3- and TLR7-dependent type I interferon (IFN) immunity or to autoantibodies against type I IFN, account for 15–20% of cases of life-threatening COVID-19 in unvaccinated patients. Therefore, the determinants of life-threatening COVID-19 remain to be identified in ~ 80% of cases.
Methods
We report here a genome-wide rare variant burden association analysis in 3269 unvaccinated patients with life-threatening COVID-19, and 1373 unvaccinated SARS-CoV-2-infected individuals without pneumonia. Among the 928 patients tested for autoantibodies against type I IFN, a quarter (234) were positive and were excluded.
Results
No gene reached genome-wide significance. Under a recessive model, the most significant gene with at-risk variants was TLR7, with an OR of 27.68 (95%CI 1.5–528.7, P = 1.1 × 10−4) for biochemically loss-of-function (bLOF) variants. We replicated the enrichment in rare predicted LOF (pLOF) variants at 13 influenza susceptibility loci involved in TLR3-dependent type I IFN immunity (OR = 3.70[95%CI 1.3–8.2], P = 2.1 × 10−4). This enrichment was further strengthened by (1) adding the recently reported TYK2 and TLR7 COVID-19 loci, particularly under a recessive model (OR = 19.65[95%CI 2.1–2635.4], P = 3.4 × 10−3), and (2) considering as pLOF branchpoint variants with potentially strong impacts on splicing among the 15 loci (OR = 4.40[9%CI 2.3–8.4], P = 7.7 × 10−8). Finally, the patients with pLOF/bLOF variants at these 15 loci were significantly younger (mean age [SD] = 43.3 [20.3] years) than the other patients (56.0 [17.3] years; P = 1.68 × 10−5).
Conclusions
Rare variants of TLR3- and TLR7-dependent type I IFN immunity genes can underlie life-threatening COVID-19, particularly with recessive inheritance, in patients under 60 years old.
Rights
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Cite as
Matuozzo, D., Talouarn, E., Marchal, A., Zhang, P., Manry, J., Seeleuthner, Y., Zhang, Y., Bolze, A., Chaldebas, M., Milisavljevic, B., Gervais, A., Bastard, P., Asano, T., Bizien, L., Barzaghi, F., Abolhassani, H., Abou Tayoun, A., Aiuti, A., Alavi Darazam, I., Allende, L., Alonso-Arias, R., Arias, A., Aytekin, G., Bergman, P., Bondesan, S., Bryceson, Y., Bustos, I., Cabrera-Marante, O., Carcel, S., Carrera, P., Casari, G., Chaïbi, K., Colobran, R., Condino-Neto, A., Covill, L., Delmonte, O., El Zein, L., Flores, C., Gregersen, P., Gut, M., Haerynck, F., Halwani, R., Hancerli, S., Hammarström, L., Hatipoglu, N., Karbuz, A., Keles, S., Kyheng, C., Leon-Lopez, R., Franco, J., Mansouri, D., Martinez-Picado, J., Metin Akcan, O., Migeotte, I., Morange, P., Morelle, G., Martín-Nalda, A., Novelli, G., Novelli, A., Özçelik, T., Palabiyik, F., Pan-Hammarström, Q., de Diego, R., Planas-Serra, L., Pleguezuelo, D., Prando, C., Pujol, A., Reyes, L., Rivière, J., Rodríguez-Gallego, C., Rojas, J., Rovere-Querini, P., Schlüter, A., Shahrooei, M., Sobh, A., Soler-Palacín, P., Tandjaoui-Lambiotte, Y., Tipu, I., Tresoldi, C., Troya, J., van de Beek, D., Zatz, M., Zawadzki, P., Al-Muhsen, S., Alosaimi, M., Alsohime, F., Baris-Feldman, H., Butte, M., Constantinescu, S., Cooper, M., Dalgard, C., Fellay, J., Heath, J., Lau, Y., Lifton, R., Maniatis, T., Mogensen, T., von Bernuth, H., Lermine, A., Vidaud, M., Boland, A., Deleuze, J., Nussbaum, R., Kahn-Kirby, A., Mentre, F., Tubiana, S., Gorochov, G., Tubach, F., Hausfater, P., Meyts, I., Zhang, S., Puel, A., Notarangelo, L., Boisson-Dupuis, S., Su, H., Boisson, B., Jouanguy, E., Casanova, J., Zhang, Q., Abel, L., Cobat, A., Covid Human Genetic Effort, COVIDeF Study Group, French Covid Cohort Study, COV-Contact-Cohort, COVID-Storm Clinicians, Covid Clinicians, Orchestra Working Group, Amsterdam UMC COVID-19 Biobank & NIAID-USUHS Covid Study Group 2023, 'Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19', Genome Medicine, 15, article no: 22. https://doi.org/10.1186/s13073-023-01173-8